01 January 1999
Low-dose aspirin and serum lipoprotein(a) concentrations in patients with EPH-gestosisFranciszek Kokot, Christian Wanner, Violetta Ciszek, Edward Franek
Med Sci Monit 1999; 5(1): CR55-57 :: ID: 505214
Introduction: Lipoprotein(a) due to its thrombogenic properties, probably plays an important role in EPHgestosis vascular injury patients. Aspirin may influence the relationship between lp(a) and vascular pathology.Material and methods: This study assessed serum Lp(a) levels in 45 healthy pregnant women (HPW), 27 women with mild or moderate gestosis and in 30 non-pregnant women. Gestosis patients comprised 10 women treated with low-dose aspirin (0.15 g/day) during the last three months of pregnancy (Asp-EPH group) and 17 women who did not receive the drug (Non-Asp-EPH group). In EPH-gestosis subjects, Lp(a) concentrations were assessed (by means of a nephelometric immunoassay method) from blood samples withdrawn three months before delivery and at the day of the expected delivery, while in HPW only during the day of expected delivery. Results: Serum Lp(a) concentration levels at term of expected delivery were of similar magnitude in HPW, Asp-EPH and Non-Asp-EPH patients (27.3±4.4 vs. 39.8±14.1 vs. 26.3±4.6 mg/dl). Although these values exceeded those of the control group (17.7±4.4 mg/dl) the difference was statistically insignificant (all values as mean±SEM). In Asp-EPH and Non-Asp-EPH women, serum Lp(a) concentrations did not change significantly during the last three months of pregnancy (from 29.3±10.4 to 39.8±14.1 and from 36.2±5.6 to 26.3±4.6 mg/dl, respectively). Conclusions: Pregnant women with mild or moderate gestosis demonstrate serum Lp(a) levels of similar magnitude as HPW. Low-dose aspirin treatment for three months does not significantly influence serum Lp(a) concentrations in EPH-gestosis patients.
Keywords: Lp(a), EPH-gestosis
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
05 Jun 2023 : Clinical ResearchComparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segm...
Med Sci Monit In Press; DOI: 10.12659/MSM.940249
05 Jun 2023 : Laboratory ResearchComparison of Composite Resin (Duo-Shade) Shade Guide with Vita Ceramic Shades Before and After Chemical an...
Med Sci Monit In Press; DOI: 10.12659/MSM.940949
02 Jun 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
01 Jun 2023 : Clinical ResearchRoot Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940472
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952